R Mager1, M P Brandt2, H Borgmann2, K M Gust3, A Haferkamp2, M Kurosch2. 1. Department of Urology and Pediatric Urology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. rene.mager@unimedizin-mainz.de. 2. Department of Urology and Pediatric Urology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. 3. Department of Urology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Abstract
PURPOSE: To investigate the learning curve of a novice in MRI/TRUS software fusion biopsy and to compare his results with the expert standard at our institution. METHODS: Overall 126 MRI/TRUS fusion-guided transrectal biopsies were performed using an electromagnetic tracking ultrasonography platform. The learning progress of the novice was evaluated comparing his initial 42 procedures (group A) with his following 42 (group B). The institution's expert standard (group C), which was compared to the novice's groups, was defined by the expert's experience of 42 MRI/TRUS fusion biopsies. Primary learning curve parameters were targeted biopsy detection quotient and biopsy time. RESULTS: Overall detection of prostate cancer was 64% (27/42), 62% (26/42) and 62% (26/42) in groups A, B and C, respectively. The median target biopsy detection quotient significantly increased (p = 0.04) in group B (0.75, interquartile range (IQR) 0.25-1.0) compared to group A. (0.33, IQR 0.2-0.5). Group C revealed a median detection quotient of 0.5 (IQR 0.25-0.76) that did not differ significantly from the novice's groups (p = 0.2). Median biopsy time was significantly higher in group A (45 min, IQR 33-50 min) compared to groups B (25 min, IQR 23-29 min) and C (24 min, IQR 16-46 min) (p < 0.01). CONCLUSIONS: The present study revealed the individual learning curve of a novice in MRI/TRUS fusion biopsy and demonstrated significant learning progress regarding targeted biopsy detection quotient and biopsy time.
PURPOSE: To investigate the learning curve of a novice in MRI/TRUS software fusion biopsy and to compare his results with the expert standard at our institution. METHODS: Overall 126 MRI/TRUS fusion-guided transrectal biopsies were performed using an electromagnetic tracking ultrasonography platform. The learning progress of the novice was evaluated comparing his initial 42 procedures (group A) with his following 42 (group B). The institution's expert standard (group C), which was compared to the novice's groups, was defined by the expert's experience of 42 MRI/TRUS fusion biopsies. Primary learning curve parameters were targeted biopsy detection quotient and biopsy time. RESULTS: Overall detection of prostate cancer was 64% (27/42), 62% (26/42) and 62% (26/42) in groups A, B and C, respectively. The median target biopsy detection quotient significantly increased (p = 0.04) in group B (0.75, interquartile range (IQR) 0.25-1.0) compared to group A. (0.33, IQR 0.2-0.5). Group C revealed a median detection quotient of 0.5 (IQR 0.25-0.76) that did not differ significantly from the novice's groups (p = 0.2). Median biopsy time was significantly higher in group A (45 min, IQR 33-50 min) compared to groups B (25 min, IQR 23-29 min) and C (24 min, IQR 16-46 min) (p < 0.01). CONCLUSIONS: The present study revealed the individual learning curve of a novice in MRI/TRUS fusion biopsy and demonstrated significant learning progress regarding targeted biopsy detection quotient and biopsy time.
Authors: Winston E Barzell; Myron R Melamed; Paul Cathcart; Caroline M Moore; Hashim U Ahmed; Mark Emberton Journal: J Urol Date: 2012-07-19 Impact factor: 7.450
Authors: M Minhaj Siddiqui; Soroush Rais-Bahrami; Baris Turkbey; Arvin K George; Jason Rothwax; Nabeel Shakir; Chinonyerem Okoro; Dima Raskolnikov; Howard L Parnes; W Marston Linehan; Maria J Merino; Richard M Simon; Peter L Choyke; Bradford J Wood; Peter A Pinto Journal: JAMA Date: 2015-01-27 Impact factor: 56.272
Authors: Annerleim Walton Diaz; Anthony N Hoang; Baris Turkbey; Cheng William Hong; Hong Truong; Todd Sterling; Soroush Rais-Bahrami; M Minhaj Siddiqui; Lambros Stamatakis; Srinivas Vourganti; Jeffrey Nix; Jennifer Logan; Colette Harris; Michael Weintraub; Celene Chua; Maria J Merino; Peter Choyke; Bradford J Wood; Peter A Pinto Journal: J Urol Date: 2013-06-18 Impact factor: 7.450
Authors: Kalyan C Latchamsetty; Lester S Borden; Christopher R Porter; Marc Lacrampe; Matthew Vaughan; Eugene Lin; Neal Conti; Jonathan L Wright; John M Corman Journal: Can J Urol Date: 2007-02 Impact factor: 1.344
Authors: Joseph L Chin; Michele Billia; James Relle; Matthias C Roethke; Ionel V Popeneciu; Timur H Kuru; Gencay Hatiboglu; Maya B Mueller-Wolf; Johann Motsch; Cesare Romagnoli; Zahra Kassam; Christopher C Harle; Jason Hafron; Kiran R Nandalur; Blaine A Chronik; Mathieu Burtnyk; Heinz-Peter Schlemmer; Sascha Pahernik Journal: Eur Urol Date: 2016-01-06 Impact factor: 20.096
Authors: Timur H Kuru; Matthias C Roethke; Philip Rieker; Wilfried Roth; Michael Fenchel; Markus Hohenfellner; Heinz-Peter Schlemmer; Boris A Hadaschik Journal: BJU Int Date: 2013-08-13 Impact factor: 5.588
Authors: Willemien van den Bos; D M de Bruin; A van Randen; M R W Engelbrecht; A W Postema; B G Muller; I M Varkarakis; A Skolarikos; C D Savci-Heijink; R R Jurhill; P J Zondervan; M P Laguna Pes; H Wijkstra; T M de Reijke; J J M C H de la Rosette Journal: Eur Radiol Date: 2015-10-08 Impact factor: 5.315
Authors: Niklas Westhoff; Henning Haumann; Maximilian Christian Kriegmair; Jost von Hardenberg; Johannes Budjan; Stefan Porubsky; Maurice Stephan Michel; Patrick Honeck; Manuel Ritter Journal: World J Urol Date: 2018-12-17 Impact factor: 4.226
Authors: Emanuel Darius Cata; Charles Van Praet; Iulia Andras; Pierre Kadula; Razvan Ognean; Maximilian Buzoianu; Daniel Leucuta; Cosmin Caraiani; Attila Tamas-Szora; Karel Decaestecker; Ioan Coman; Nicolae Crisan Journal: Transl Androl Urol Date: 2021-05
Authors: Magdalena Görtz; Joanne Nyaboe Nyarangi-Dix; Lars Pursche; Viktoria Schütz; Philipp Reimold; Constantin Schwab; Albrecht Stenzinger; Holger Sültmann; Stefan Duensing; Heinz-Peter Schlemmer; David Bonekamp; Markus Hohenfellner; Jan Philipp Radtke Journal: Cancers (Basel) Date: 2022-02-10 Impact factor: 6.639
Authors: Manuel Ritter; Niklas Westhoff; Fabian Derigs; Samuel Doryumu; Fabian Tollens; Dominik Nörenberg; Manuel Neuberger; Jost von Hardenberg; Maurice Stephan Michel Journal: World J Urol Date: 2021-11-26 Impact factor: 4.226
Authors: Armando Stabile; Francesco Giganti; Veeru Kasivisvanathan; Gianluca Giannarini; Caroline M Moore; Anwar R Padhani; Valeria Panebianco; Andrew B Rosenkrantz; Georg Salomon; Baris Turkbey; Geert Villeirs; Jelle O Barentsz Journal: Eur Urol Oncol Date: 2020-03-17
Authors: Keiran D Clement; Lizzy Day; Helen Rooney; Matt Neilson; Fiona Birrell; Mark Salji; Elizabeth Norman; Ross Clark; Amit Patel; John Morrison; Hing Y Leung Journal: Asian J Androl Date: 2021 May-Jun Impact factor: 3.285